The deposition of coatings enabling antibacterial properties in combination with cytocompatibility remains a challenge for biomaterial applications, such as in medical devices. Silver is one of the most utilized antibacterial surface components, due to its efficacy and extensive applicability. In this work, silver-containing plasma polymer nanocomposites (single layer and multilayers) were developed and tested, with a focus on cytotoxicity and bactericidal function, on the NIH3T3 mammalian cell line as well as Gram-negative (Pseudomonas aeruginosa) and Gram-positive (Staphylococcus aureus) bacterial strains. The data demonstrate that a tuneable Ag+ release is required, allowing sufficient antimicrobial activity while retaining appropriate cytocompatibility over the entire testing period of up to eight days.
PaladiniFPolliniMTalaAet al.
Efficacy of silver treated catheters for haemodialysis in preventing bacterial adhesion. J Mater Sci2012;
23: 1983–1990.
11.
SecerHIKuralCKaplanMet al.
Comparison of the efficacies of antibiotic-impregnated and silver-impregnated ventricular catheters on the prevention of infections. Pediatr Neurosurg2008;
44: 444–447.
12.
StevensKNJCroesSBoersmaRSet al.
Hydrophilic surface coatings with embedded biocidal silver nanoparticles and sodium heparin for central venous catheters. Biomaterials2011;
32: 1264–1269.
13.
Heidari ZareHJuhartVVassAet al.
Efficacy of silver/hydrophilic poly(p-xylylene) on preventing bacterial growth and biofilm formation in urinary catheters. Biointerphases2017;
12: 011001.
14.
TkachenkoOKarasJA.Standardizing an in vitro procedure for the evaluation of the antimicrobial activity of wound dressings and the assessment of three wound dressings. J Antimicrob Chemother2012; 67: 1697–1700.
15.
SinglaRSoniSPatialVet al.
Cytocompatible anti-microbial dressings of syzygium cumini cellulose nanocrystals decorated with silver nanoparticles accelerate acute and diabetic wound healing. Sci Rep2017;
7: 10457.
16.
MosselhyDGranbohmHHynönenUet al.
Nanosilver–silica composite: prolonged antibacterial effects and bacterial interaction mechanisms for wound dressings. Nanomaterials2017;
7: 261.
17.
GorjancMBukošekVGorenšekMet al.
CF4 plasma and silver functionalized cotton. Text Res J2010;
80: 2204–2213.
Silvestry-RodriguezNSicairos-RuelasEEGerbaCPet al.Silver as a disinfectant reviews of environmental contamination and toxicology.
New York: Springer, 2007, pp.23–45.
20.
MeiLTengZZhuGet al.
Silver nanocluster-embedded zein films as antimicrobial coating materials for food packaging. ACS Appl Mater Interf2017; 9: 35297–35304.
21.
MilgromPHorstJALudwigSet al.
Topical silver diamine fluoride for dental caries arrest in preschool children: a randomized controlled trial and microbiological analysis of caries associated microbes and resistance gene expression. J Dentistry2018; 68: 72–78.
22.
ChernousovaSEppleM.Silver as antibacterial agent: ion, nanoparticle, and metal. Angew Chem Int Ed Engl2013;
52: 1636–1653.
23.
MahmoudiMSerpooshanV.Silver-coated engineered magnetic nanoparticles are promising for the success in the fight against antibacterial resistance threat. ACS Nano2012;
6: 2656–2664.
24.
MohantySMishraSJenaPet al.
An investigation on the antibacterial, cytotoxic, and antibiofilm efficacy of starch-stabilized silver nanoparticles. Nanomedicine2012;
8: 916–924. Epub 2011/11/26.
25.
ZhangMZhangKDe GussemeBet al.
Biogenic silver nanoparticles (bio-Ag0) decrease biofouling of bio-Ag0/PES nanocomposite membranes. Water Res2012;
46: 2077–2087.
26.
Shayani RadMKhamenehBSabetiZet al.
Antibacterial activity of silver nanoparticle-loaded soft contact lens materials: the effect of monomer composition. Curr Eye Res2016;
41: 1286–1293.
27.
DarouicheRO.Treatment of infections associated with surgical implants. N Engl J Med2004;
350: 1422–1429.
28.
SchierholzJMMorsczeckCBrennerNet al.
[Special aspects of implant-associated infection in orthopedic surgery. From the pathophysiology to custom-tailored prevention strategies]. Orthopade2004;
33: 397–404.
29.
LebeauxDChauhanARenduelesOet al.
From in vitro to in vivo models of bacterial biofilm-related infections. Pathogens2013;
2: 288–356.
30.
DonelliGVuottoC.Biofilm-based infections in long-term care facilities. Future Microbiol2014;
9: 175–188.
31.
Mara MadalinaMAlina MariaHCalinGet al.
Microbial biofilms: impact on the pathogenesis of periodontitis, cystic fibrosis, chronic wounds and medical device-related infections. Curr Top Med Chem2015;
15: 1552–1576.
32.
SheridanRLPetrasLLydonMet al.
Once-daily wound cleansing and dressing change: efficacy and cost. J Burn Care Rehabil1997;
18: 139–140.
33.
TanLKasliwalMTraynelisV.Infection with spinal instrumentation: review of pathogenesis, diagnosis, prevention, and management. Surg Neurol Int2013;
4(Suppl 5): S392–403.
34.
KaschRMerkSAssmannGet al.
Comparative analysis of direct hospital care costs between aseptic and two-stage septic knee revision. PLoS One2017;
12: e0169558.
35.
HaddadFSNguANegusJJ.Prosthetic joint infections and cost analysis? In: DragoL (ed) A modern approach to biofilm-related orthopaedic implant infections: advances in microbiology, infectious diseases and public health.
Vol.5.
Cham:
Springer International Publishing, 2017, pp.93–100.
36.
MooneyEKLippittCFriedmanJ.Plastic surgery educational foundation DC. Silver dressings. Plast Reconstruct Surg2006;
117: 666–669. 10.1097/01.prs.0000200786.14017.3a.
37.
FengQLWuJChenGQet al.
A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res2000;
52: 662–668.
38.
JungWKKooHCKimKWet al.
Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Appl Environment Microbiol2008;
74: 2171–2178.
39.
LiP-WKuoT-HChangJ-Het al.
Induction of cytotoxicity and apoptosis in mouse blastocysts by silver nanoparticles. Toxicol Lett2010;
197: 82–87.
40.
ShavandiZGhazanfariTMoghaddamKN.In vitro toxicity of silver nanoparticles on murine peritoneal macrophages. Immunopharmacol Immunotoxicol2011;
33: 135–140.
41.
ThomasGWRaelLTBar-OrRet al.
Mechanisms of delayed wound healing by commonly used antiseptics. J Trauma Acute Care Surg2009;
66: 82–91. 10.1097/TA.0b013e31818b146d.
42.
Verano-BragaTMiethling-GraffRWojdylaKet al.
Insights into the cellular response triggered by silver nanoparticles using quantitative proteomics. ACS Nano2014;
8: 2161–2175.
43.
AroraSJainJRajwadeJMet al.
Interactions of silver nanoparticles with primary mouse fibroblasts and liver cells. Toxicol Appl Pharmacol2009;
236: 310–318.
44.
CostaCRonconiJDaufenbachJet al.
In vitro effects of silver nanoparticles on the mitochondrial respiratory chain. Mol Cell Biochem2010;
342: 51–56.
45.
HussainSMHessKLGearhartJMet al.
In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol in Vitro2005;
19: 975–983.
46.
LeeY-HChengF-YChiuH-Wet al.
Cytotoxicity, oxidative stress, apoptosis and the autophagic effects of silver nanoparticles in mouse embryonic fibroblasts. Biomaterials2014;
35: 4706–4715.
47.
AroraSJainJRajwadeJMet al.
Cellular responses induced by silver nanoparticles: in vitro studies. Toxicol Lett2008;
179: 93–100.
48.
ElkonKBIL.1[alpha] responds to necrotic cell death. Nat Med2007;
13: 778–780.
49.
FestjensNVanden BergheTVandenabeeleP.Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response. Biochim Biophys Acta2006;
1757: 1371–1387.
50.
ProskuryakovSYaKonoplyannikovAGGabaiVL.Necrosis: a specific form of programmed cell death?Exp Cell Res2003;
283: 1–16.
51.
KörnerEAguirreM, HFortunatoGet al.
Formation and distribution of silver nanoparticles in a functional plasma polymer matrix and related Ag release properties. Plasma Process Polym2010;
7: 619–625.
52.
BiedermanHMartinuLSlavinskaDet al.
Plasma deposition and properties of composite metal/polymer and metal/hard carbon films. Pure Appl Chemist1988;
60: 607–618.
53.
KörnerEFortunatoGHegemannD.Influence of RF plasma reactor setup on carboxylated hydrocarbon coatings. Plasma Process Polym2009;
6: 119–125.
54.
SengPBayleSAlliezAet al.
The microbial epidemiology of breast implant infections in a regional referral centre for plastic and reconstructive surgery in the south of France. Int J Infect Dis2015;
35: 62–66.
55.
MalzahnKDuqueLCiernakPet al.
Antimicrobial Activity and cyto-compatibility of plasma polymerized zinc acetylacetonate thin films. Plasma Process Polym2013;
10: 243–249.
56.
KörnerERupperPLübbenJFet al.
Surface topography, morphology and functionality of silver containing plasma polymer nanocomposites. Surf Coat Technol2011;
205: 2978–2984.
57.
HegemannDKörnerEAlbrechtKet al.
Growth mechanism of oxygen-containing functional plasma polymers. Plasma Process Polym2010;
7: 889–898.
58.
DrábikMPešičkaJBiedermanHet al.
Long-term aging of Ag/a-C:H:O nanocomposite coatings in air and in aqueous environment. Sci Technol Adv Mater2015;
16: 025005.
59.
Grigor’evaASaraninaITikunovaNet al.
Fine mechanisms of the interaction of silver nanoparticles with the cells of Salmonella typhimurium and Staphylococcus aureus. Biometals2013;
26: 479–488.
60.
ShrivastavaSBeraTRoyAet al.
Characterization of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnology2007;
18: 225103.
61.
TamboliDPLeeDS.Mechanistic antimicrobial approach of extracellularly synthesized silver nanoparticles against gram positive and gram negative bacteria. J Hazard Mater2013;
260: 878–884.
62.
PozdnyakovASEmel’yanovAIKuznetsovaNPet al.
Nontoxic hydrophilic polymeric nanocomposites containing silver nanoparticles with strong antimicrobial activity. Int J Nanomed2016;
11: 1295–1304.
63.
TagliettiADiaz FernandezYAAmatoEet al.
Antibacterial activity of glutathione-coated silver nanoparticles against gram positive and gram negative bacteria. Langmuir2012;
28: 8140–8148.
64.
MirhosseiniMFirouzabadiFB.Antibacterial activity of zinc oxide nanoparticle suspensions on food-borne pathogens. Int J Dairy Technol2013;
66: 291–295.
65.
ZanniEBruniEChandraiahgariCRet al.
Evaluation of the antibacterial power and biocompatibility of zinc oxide nanorods decorated graphene nanoplatelets: new perspectives for antibiodeteriorative approaches. J Nanobiotechnol2017;
15: 57.
DammCMünstedtHRöschA.The antimicrobial efficacy of polyamide 6/silver-nano- and microcomposites. Mater Chem Phys2008;
108: 61–66.
68.
MeaumeSValletDMorereMNet al.
Evaluation of a silver-releasing hydroalginate dressing in chronic wounds with signs of local infection. J Wound Care2005;
14: 411–419.
69.
WuXLiJWangLet al.
The release properties of silver ions from Ag-nHA/TiO2/PA66 antimicrobial composite scaffolds. Biomed Mater2010; 5: 044105.
70.
HuangXBrazelCS.On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release2001;
73: 121–136.
71.
HeTChanV.Covalent layer-by-layer assembly of polyethyleneimine multilayer for antibacterial applications. J Biomed Mater Res A2010;
95A: 454–464.
72.
LeeDCohenRERubnerMF.Antibacterial properties of Ag nanoparticle loaded multilayers and formation of magnetically directed antibacterial microparticles. Langmuir2005;
21: 9651–9659.
73.
LiWXuDHuYet al.
Surface modification of titanium substrates with silver nanoparticles embedded sulfhydrylated chitosan/gelatin polyelectrolyte multilayer films for antibacterial application. J Mater Sci2014; 25: 1435–1448.
74.
LischerSKörnerEBalazsDJet al.
Antibacterial burst-release from minimal Ag-containing plasma polymer coatings. J R Soc Interf2011;
8: 1019–1030.
75.
MalcherMVolodkinDHeurtaultBaet al.
Embedded silver ions-containing liposomes in polyelectrolyte multilayers: cargos films for antibacterial agents. Langmuir2008;
24: 10209–10215.
76.
McLeanRJCHussainAASayerMet al.
Antibacterial activity of multilayer silver–copper surface films on catheter material. Can J Microbiol. 1993;
39: 895–899.
77.
YinHQLangfordRBurrellRE.Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. J Burn Care Rehabil1999;
20: 195–200.
78.
WangXCaoWXiangQet al.
Silver nanoparticle and lysozyme/tannic acid layer-by-layer assembly antimicrobial multilayer on magnetic nanoparticle by an eco-friendly route. Mater Sci Eng C2017;
76: 886–896.
79.
SychevDMayaIDAllonM.Clinical management of dialysis catheter-related bacteremia with concurrent exit-site infection. Semin Dial2011;
24: 239–241.
80.
von EiffCJansenBKohnenWet al.
Infections associated with medical devices: pathogenesis, management and prophylaxis. Drugs2005;
65: 179–214.
81.
WangLLansingBSymonsKet al.
Infection rate and colonization with antibiotic-resistant organisms in skilled nursing facility residents with indwelling devices. Eur J Clin Microbiol Infect Dis2012; 31: 1797–1804.
82.
MurdochDRRobertsSAFowlerVGJret al.
Infection of orthopedic prostheses after Staphylococcus aureus bacteremia. Clin Infect Dis2001;
32: 647–649.
83.
TeteryczDFerryTLewDet al.
Outcome of orthopedic implant infections due to different staphylococci. Int J Infect Dis2010;
14: e913–e9e8.
84.
VilchezFMartinez-PastorJCGarcia-RamiroSet al.
Efficacy of debridement in hematogenous and early post-surgical prosthetic joint infections. Int J Artif Organs2011;
34: 863–869. Epub 2011/11/19.
85.
WagnerCHänschGM.Mechanisms of Bacterial Colonization of Implants and Host Response. In: DragoL, editor. A modern approach to biofilm-related orthopaedic implant infections: advances in microbiology, infectious diseases and public health.
Volume 5.
Cham:
Springer International Publishing, 2017, pp.15–27.
86.
O'GradyNPAlexanderMBurnsLAet al.
Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control2011;
39: S1–S34.
87.
AshaRaniPVLow Kah MunGHandeMPet al.
Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano2009;
3: 279–290.
88.
GopinathPGogoiSKSanpuiPet al.
Signaling gene cascade in silver nanoparticle induced apoptosis. Colloids Surf B Biointerf2010;
77: 240–245.
89.
HsinY-HChenC-FHuangSet al.
The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol Lett2008;
179: 130–139.
90.
FoldbjergROlesenPHougaardMet al.
PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes. Toxicol Lett2009;
190: 156–162.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
